‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
2:31
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
Mar 3, 2021
Hindustan TimesMohammad Shuaib
Bharat Biotech announces price of nasal vaccine - Check How Much It Costs?
Bharat Biotech announces price of nasal vaccine - Check How Much It Costs?
Dec 27, 2022
zeebiz.com
Bharat Biotech caps Covaxin price, Rs 600 for states, Rs 1200 for private hospitals
Bharat Biotech caps Covaxin price, Rs 600 for states, Rs 1200 for private hospitals
Apr 24, 2021
india.com
COVID-19: Bharat Biotech confirms adverse event during vaccine trial
COVID-19: Bharat Biotech confirms adverse event during vaccine trial
Nov 21, 2020
india.com
#BharatBiotech decides to reduce the price of its COVID-19 vaccine #Covaxin from Rs 600 per dose to Rs 400 per dose for the states This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose | Hindustan Times
1:26
#BharatBiotech decides to reduce the price of its COVID-19 vaccine #Covaxin from Rs 600 per dose to Rs 400 per dose for the states This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose | Hindustan Times
2.7K viewsApr 29, 2021
FacebookHindustan Times
Covaxin manufacturer Bharat Biotech to carry out clinical trials in US
Covaxin manufacturer Bharat Biotech to carry out clinical trials in US
Jun 12, 2021
INDIA TV
Bharat Biotech gets nod to run trials for nasal COVID vaccine as booster dose - CNBC TV18
3:33
Bharat Biotech gets nod to run trials for nasal COVID vaccine as booster dose - CNBC TV18
Jan 4, 2022
cnbctv18.com
2:55
Joining the race for a COVID vaccine, Bharat Biotech has said that they have aimed the rollout of Covaxin by mid-2021, pending approval. | News18
1.2K viewsNov 22, 2020
FacebookNews18
Covid-19 vaccine: Expert panel seeks clarifications from Bharat Biotech ahead of 'Covaxin' phase-3 trials
Oct 10, 2020
India TodayIndia Today Web Desk
Covaxin vaccine to be available in first quarter of next year: Bharat Biotech
Dec 9, 2020
oneindia.com
Bharat Biotech releases Phase 3 results of Covaxin, says it shows 81% interim clinical efficacy
Mar 3, 2021
India TodayAshish Pandey
4:01
The Indian Council of Medical Research (ICMR) has set an ambitious launch date of August 15 for the public use of the Coronavirus vaccine being developed in partnership with Hyderabad-based Bharat Biotech. | News18
155.3K viewsJul 3, 2020
FacebookNews18
7:04
Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV
46.1K viewsApr 28, 2020
FacebookNDTV
Bharat Biotech To Be Reportedly Valued At $600 Million As Top PE Firms Queue Up To Buy Stake
Feb 7, 2016
marketscreener.com
2:28
Bharat Biotech announces interim analysis results of Phase3 trials Track latest news updates https://bit.ly/2Qo1kkm | The Economic Times
14.7K viewsApr 21, 2021
FacebookThe Economic Times
India’s Bharat Biotech applies for emergency use authorization in PH for its COVID-19 vaccine | ABS-CBN News
Jan 21, 2021
abs-cbn.com
Serum Institute, Bharat Biotech need to submit more data on Covid-19 vaccines
Dec 9, 2020
oneindia.com
1:05
Animal trials of Bharat Biotech vaccine candidate Covaxin successful
Sep 12, 2020
India TodayIndia Today Television
2:53
A letter by the ICMR asked the company to launch Covaxin by August 15. Bharat Biotech has been asked to accelerate its trails as well and to adhere to the timelines. even DCGI has cleared 'Covaxin' trails. | News18
10.4K viewsJul 4, 2020
FacebookNews18
1:57
Bharat Biotech Says Phase 3 Results Public By July
Jun 9, 2021
NDTVVishnu Som
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid vaccines
May 13, 2021
timesnownews.com
2:25
Bharat Biotech has sent a request for conducting phase 1 trials of its nasal COVID-19 vaccine. A high-level panel will soon decide on the request. | News18
743 viewsJan 8, 2021
FacebookNews18
10:26
Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
Jul 3, 2021
NDTV
Bharat Biotech's Covid Nasal Vaccine Gets Regulator's Nod For Holding Phase 2, 3 Clinical Trials
Aug 13, 2021
abplive.com
1:54
Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data
Jul 3, 2021
NDTVUma Sudhir
Inactivated vaccines safest with lesser adverse reactions: Bharat Biotech
Dec 21, 2020
INDIA TV
COVID-19 vaccine: Bharat BioTech and Ocugen team up to develop Covaxin for US market
Dec 22, 2020
india.com
India's Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028
10 months ago
bluewaterhealthyliving.com
Bharat Biotech to ramp up Covaxin production to additional 200 million doses per year
May 20, 2021
india.com
0:50
Bharat Biotech, Serum Institute announce vaccine prices ahead of May 1
Apr 25, 2021
India TodayIndia Today Television
See more
Static thumbnail place holder